Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,065 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The role of oxysterol binding protein-related protein 5 in pancreatic cancer.
Ishikawa S, Nagai Y, Masuda T, Koga Y, Nakamura T, Imamura Y, Takamori H, Hirota M, Funakosi A, Fukushima M, Baba H. Ishikawa S, et al. Among authors: hirota m. Cancer Sci. 2010 Apr;101(4):898-905. doi: 10.1111/j.1349-7006.2009.01475.x. Epub 2009 Dec 16. Cancer Sci. 2010. PMID: 20128820
PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis.
Tsukamoto M, Imai K, Ishimoto T, Komohara Y, Yamashita YI, Nakagawa S, Umezaki N, Yamao T, Kitano Y, Miyata T, Arima K, Okabe H, Baba Y, Chikamoto A, Ishiko T, Hirota M, Baba H. Tsukamoto M, et al. Among authors: hirota m. Cancer Sci. 2019 Jan;110(1):310-320. doi: 10.1111/cas.13874. Epub 2018 Dec 14. Cancer Sci. 2019. PMID: 30426611 Free PMC article.
Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N, Ohmuraya M, Ida S, Hashimoto D, Ikuta Y, Chikamoto A, Hirota M, Baba H. Ozaki N, et al. Among authors: hirota m. J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6. J Hepatobiliary Pancreat Sci. 2013. PMID: 23475261
1,065 results